Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -20.210% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
[a] COc1ccc(CCNS(=O)(=O)c2cc3c4c(c2)CCN4C(=O)CC3)cc1
[b] CCOC(=O)C1=C(C)N(c2ccccc2)C(=O)/C1=C\c1cccs1
[c] FC(F)(F)Oc1ccc(NC(=S)Nc2ccc(OC(F)(F)F)cc2)cc1
[d] COc1cc2cc(C(=O)N/N=C/c3ccc(F)cc3)[nH]c2cc1OC
[e] Cc1ccc(S(=O)(=O)/N=C/c2cc(Br)ccc2O)cc1
Answer: a. COc1ccc(CCNS(=O)(=O)c2cc3c4c(c2)CCN4C(=O)CC3)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CCNS(=O)(=O)c2cc3c4c(c2)CCN4C(=O)CC3)cc1
COc1ccc(CCNS(=O)(=O)c2cc3c4c(c2)CCN4C(=O)CC3)cc1
N-[2-(4-methoxyphenyl)ethyl]-11-oxo-1-azatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-triene-6-sulfonamide